Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pulmonx (LUNG) and Bristol-Myers Squibb (BMY)
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Cuts Target Price to $6
Pulmonx Is Maintained at Buy by Canaccord Genuity
Pulmonx Price Target Cut to $15.00/Share From $16.00 by Canaccord Genuity
Piper Sandler Reiterates Overweight on Pulmonx, Lowers Price Target to $9
Pulmonx Analyst Ratings
D. Boral Capital Maintains Buy on Pulmonx, Maintains $17 Price Target
Lake Street Initiates Pulmonx(LUNG.US) With Buy Rating, Announces Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), Pulmonx (LUNG)
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Pulmonx Poised for Growth: Buy Rating Backed by Strong Leadership and Attractive Valuation
D. Boral Capital Initiates Coverage On Pulmonx With Buy Rating, Announces Price Target of $17
Pulmonx Analyst Ratings
D. Boral Capital Initiates Pulmonx(LUNG.US) With Buy Rating, Announces Target Price $17
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Keeps Their Buy Rating on Pulmonx (LUNG)
Citi Maintains Pulmonx(LUNG.US) With Hold Rating